Prot#251PP301:A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BIIB092 in Participants with Progressive Supranuclear Palsy

Project: Research project

Project Details

StatusFinished
Effective start/end date10/24/1710/24/20

Funding

  • ICON Clinical Research, LLC (Prot#CN002012)
  • Bristol-Myers Squibb Company (Prot#CN002012)